Used in pharmaceutical research as an intermediate for synthesizing bioactive molecules, particularly in the development of proteolysis-targeting chimeras (PROTACs). Its structure allows for conjugation between E3 ligase ligands and target protein binders, facilitating targeted protein degradation. Also employed in the preparation of peptide-like polymers and functionalized hydrazides for biochemical assays. Shows potential in creating novel anti-cancer and anti-inflammatory agents due to its ability to form stable linkages in complex molecular architectures.